PL2400993T3 - Sterylne roztwory kwasu hialuronowego - Google Patents

Sterylne roztwory kwasu hialuronowego

Info

Publication number
PL2400993T3
PL2400993T3 PL11702563T PL11702563T PL2400993T3 PL 2400993 T3 PL2400993 T3 PL 2400993T3 PL 11702563 T PL11702563 T PL 11702563T PL 11702563 T PL11702563 T PL 11702563T PL 2400993 T3 PL2400993 T3 PL 2400993T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
acid solutions
sterile hyaluronic
sterile
solutions
Prior art date
Application number
PL11702563T
Other languages
English (en)
Inventor
Xiaojun Michael Liu
David Joseph Heiler
Thomas Menzel
Abbie Brongo
Susan E Burke
Karl Cummins
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of PL2400993T3 publication Critical patent/PL2400993T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
PL11702563T 2010-02-09 2011-01-27 Sterylne roztwory kwasu hialuronowego PL2400993T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/702,540 US8283463B2 (en) 2010-02-09 2010-02-09 Sterile hyaluronic acid solutions
PCT/US2011/022656 WO2011100114A1 (en) 2010-02-09 2011-01-27 Sterile hyaluronic acid solutions
EP11702563.5A EP2400993B1 (en) 2010-02-09 2011-01-27 Sterile hyaluronic acid solutions

Publications (1)

Publication Number Publication Date
PL2400993T3 true PL2400993T3 (pl) 2015-06-30

Family

ID=43754892

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11702563T PL2400993T3 (pl) 2010-02-09 2011-01-27 Sterylne roztwory kwasu hialuronowego

Country Status (8)

Country Link
US (2) US8283463B2 (pl)
EP (2) EP2865395A1 (pl)
JP (1) JP5789271B2 (pl)
BR (1) BR112012019008B8 (pl)
ES (1) ES2531955T3 (pl)
PL (1) PL2400993T3 (pl)
TW (1) TWI405595B (pl)
WO (1) WO2011100114A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10189773B2 (en) 2010-05-07 2019-01-29 Medicus Biosciences, Llc In-vivo gelling pharmaceutical pre-formulation
US11083821B2 (en) * 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US10111985B2 (en) * 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
ES2686114T3 (es) * 2011-12-20 2018-10-16 Angioclinic Ag El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas
EP2846847B1 (en) 2012-05-11 2020-03-25 C.P. Medical Corporation Biocompatible hydrogel treatments for retinal detachment
FR3019465B1 (fr) 2014-04-02 2017-06-23 Horus Pharma Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
EP3741351A1 (en) 2014-04-17 2020-11-25 Merz Pharma GmbH & Co. KGaA Composition for improving the appearance of ageing skin
US10245324B2 (en) 2014-10-31 2019-04-02 Johnson & Johnson Consumer Inc. Ophthalmic composition
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
DE102015226456A1 (de) 2015-12-22 2017-06-22 Heraeus Medical Gmbh Verfahren zur Sterilisation von wässrigen Polysaccharidlösungen und sterile wässrige Polysaccharidlösungen
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
EP3871682A1 (en) * 2016-10-14 2021-09-01 i.com Medical GmbH Method for establishing, restoring, and preserving homeostasis of the ocular surface
EP3675912B1 (en) * 2017-10-12 2024-01-10 SolyPlus GmbH Methods of fabrication of concentrated and homogeneously wetted massive polymers and applications thereof
CN111196917B (zh) * 2018-11-20 2022-10-14 臧唯 内窥镜用视野清晰剂
WO2021033725A1 (ja) * 2019-08-21 2021-02-25 株式会社 資生堂 化粧料
IT201900019724A1 (it) 2019-10-24 2021-04-24 Bmg Pharma S P A “procedimento in solvente organico per la purificazione dell’acido ialuronico sale sodico”
IT202000008299A1 (it) * 2020-04-17 2021-10-17 Glycores 2000 Srl Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare
KR102549875B1 (ko) * 2020-09-22 2023-07-03 주식회사 필코리아 필러 정제용 장치
CN112255345A (zh) * 2020-10-20 2021-01-22 山东华熙海御生物医药有限公司 一种测定高分子量透明质酸分子量的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
DE2837115A1 (de) 1978-08-25 1980-03-06 Bayer Ag Neues verfahren zur herstellung von sterilen feststoffen
US5093487A (en) 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
RU2067841C1 (ru) * 1994-01-28 1996-10-20 Научно-производственная фирма "Нарт" Способ получения ароматизатора
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US5621093A (en) 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
AU1735097A (en) * 1996-03-15 1997-10-01 Takara Shuzo Co., Ltd. A product of heat treatment of uronic acid, food, drink or drug including the product
KR19980080116A (ko) 1997-03-27 1998-11-25 히라따 다다시 히알루론산 나트륨의 정제법
US6149864A (en) 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
CH692919A5 (fr) 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
KR100354606B1 (ko) 2000-02-01 2002-09-30 주식회사 중외제약 다목적 콘택트 렌즈 관리 용액 조성물
FR2811996B1 (fr) * 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
CN1522161A (zh) 2001-06-29 2004-08-18 �Ȱ�ά����ķ�ɷݹ�˾ 批量高压灭菌方法
WO2003043660A2 (en) * 2001-11-21 2003-05-30 Novartis Ag Composition for stabilizing hyaluronic acid
EP1526859B1 (en) 2002-08-07 2012-10-24 Laboratoire Medidom S.A. Process for preparing a sterile high molecular weight hyaluronic acid formulation
US6930077B2 (en) 2003-09-10 2005-08-16 Advanced Medical Optics, Inc. Compositions and methods using sub-PPM combinations of polyquaternium-1 and high molecular weight PHMB
US7956180B2 (en) * 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
EP1786480B1 (en) 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
DE102005030011A1 (de) 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
WO2009063291A1 (en) * 2007-11-13 2009-05-22 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
US20110195927A1 (en) * 2008-09-15 2011-08-11 Compositions Comprising Polymers Having Aminio Sugar Unites And Methods Of Making And Using Same Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same

Also Published As

Publication number Publication date
BR112012019008A2 (pt) 2015-09-15
EP2400993A1 (en) 2012-01-04
US20120295869A1 (en) 2012-11-22
JP5789271B2 (ja) 2015-10-07
US20110195925A1 (en) 2011-08-11
US8530641B2 (en) 2013-09-10
JP2013518926A (ja) 2013-05-23
BR112012019008B8 (pt) 2018-11-27
TW201200171A (en) 2012-01-01
EP2400993B1 (en) 2014-12-31
ES2531955T3 (es) 2015-03-23
WO2011100114A1 (en) 2011-08-18
EP2865395A1 (en) 2015-04-29
BR112012019008B1 (pt) 2018-11-13
US8283463B2 (en) 2012-10-09
TWI405595B (zh) 2013-08-21

Similar Documents

Publication Publication Date Title
PL2400993T3 (pl) Sterylne roztwory kwasu hialuronowego
PL2637710T3 (pl) Preparaty na bazie kwasu hialuronowego
EP2548529A4 (en) MEDICAL MANIPULATOR
EP2543405A4 (en) SYRINGE
EP2739234A4 (en) SURGICAL ASSISTANCE SYSTEM
EP2727545A4 (en) MEDICAL MANIPULATOR
EP2554128A4 (en) MEDICAL HANDLING SYSTEM
EP2550926A4 (en) MEDICAL HANDLING SYSTEM
EP2739233A4 (en) MEDICAL MANIPULATOR
HK1180258A1 (en) Catheter
HK1183831A1 (en) Catheter
TWM389271U (en) Healthcare eyeglasses
SG10201507079WA (en) Syringe
EP2574362A4 (en) CATHETER
HK1184401A1 (en) Catheter
EP2770936A4 (en) MEDICAL MANIPULATOR
HK1176321A1 (en) Catheter
EP2535065A4 (en) dialyzer
GB201016969D0 (en) Expression system
EP2726009A4 (en) MEDICAL MANIPULATOR SYSTEM
EP2654872A4 (en) AUTODILATION CANNULA
GB201015822D0 (en) Medical ruggedised case
HK1184724A1 (zh) 具有互鎖的含藥模塊
EP2687181A4 (en) SURGICAL SYSTEM
GB201013573D0 (en) Treatment